Downregulation of SETD5 Suppresses the Tumorigenicity of Hepatocellular Carcinoma Cells
Open Access
- 5 August 2022
- journal article
- research article
- Published by Elsevier in Molecules and Cells
- Vol. 45 (8) , 550-563
Abstract
Mijin Park, Byul Moon, Jong-Hwan Kim, Seung-Jin Park, Seon-Kyu Kim, Kihyun Park, Jaehoon Kim, Seon-Young Kim, Jeong-Hoon Kim, and Jung-Ae Kim. Mol. Cells 2022;45:550-63. https://doi.org/10.14348/molcells.2022.0009Keywords
This publication has 50 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variationNucleic Acids Research, 2012
- RNA-Seq analysis in MeVBioinformatics, 2011
- DDX60, a DEXD/H Box Helicase, Is a Novel Antiviral Factor Promoting RIG-I-Like Receptor-Mediated SignalingMolecular and Cellular Biology, 2011
- Future perspectives in hepatocellular carcinomaDigestive and Liver Disease, 2010
- Histone methyltransferases in cancerSeminars in Cell & Developmental Biology, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Therapeutic targeting of MLLBlood, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Extraction, purification and analysis of histonesNature Protocols, 2007